|
Volumn 19, Issue 6, 2014, Pages 894-899
|
N-acetylcysteine administration confers lung protection in different phases of lung ischaemia-reperfusion injury
a a a a a a a |
Author keywords
Inflammation; Ischaemia reperfusion; N Acetylcysteine
|
Indexed keywords
3-NITROTYROSINE;
ACETYLCYSTEINE;
ANTIINFLAMMATORY AGENT;
ANTIOXIDANT;
AUTACOID;
CASP3 PROTEIN, RAT;
CASPASE 3;
I KAPPA B KINASE;
IL1B PROTEIN, RAT;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INDUCIBLE NITRIC OXIDE SYNTHASE;
INTERLEUKIN 1BETA;
NOS2 PROTEIN, RAT;
PEROXIDASE;
SUPEROXIDE DISMUTASE;
TUMOR NECROSIS FACTOR;
TYROSINE;
ANALOGS AND DERIVATIVES;
ANIMAL;
CELL PROTECTION;
DISEASE MODEL;
DRUG EFFECTS;
HEMODYNAMICS;
INTRAVENOUS DRUG ADMINISTRATION;
LIPID PEROXIDATION;
LUNG;
LUNG INJURY;
METABOLISM;
OXIDATIVE STRESS;
PATHOLOGY;
PATHOPHYSIOLOGY;
REPERFUSION INJURY;
TIME FACTOR;
VASCULARIZATION;
WISTAR RAT;
ACETYLCYSTEINE;
ADMINISTRATION, INTRAVENOUS;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
ANTIOXIDANTS;
CASPASE 3;
CYTOPROTECTION;
DISEASE MODELS, ANIMAL;
HEMODYNAMICS;
I-KAPPA B KINASE;
INFLAMMATION MEDIATORS;
INTERLEUKIN-1BETA;
LIPID PEROXIDATION;
LUNG;
LUNG INJURY;
NF-KAPPA B;
NITRIC OXIDE SYNTHASE TYPE II;
OXIDATIVE STRESS;
PEROXIDASE;
RATS, WISTAR;
REPERFUSION INJURY;
SUPEROXIDE DISMUTASE;
TIME FACTORS;
TUMOR NECROSIS FACTOR-ALPHA;
TYROSINE;
|
EID: 84991545134
PISSN: None
EISSN: 15699285
Source Type: Journal
DOI: 10.1093/icvts/ivu258 Document Type: Article |
Times cited : (14)
|
References (0)
|